United-Imaging-Logo

IsoRay receives CE Mark for GliaSite

AuntMinnieEurope.com staff writers
May 22, 2012

Medical isotope developer IsoRay has received the European CE Mark for its GliaSite radiation therapy system.

GliaSite is a balloon catheter device used in the treatment of brain cancer.

Latest in Molecular Imaging
PET/CT images performed at 10- and 60-minutes following injection of Ga-68 FAPI-46 (mean 181 MBq; range 143–225 MBq).
Early FAPI-PET scans match 60-minute scans for lung cancer staging
June 10, 2026
France Flag Button 400
Curium to invest €32M in French radiopharmaceutical facility
June 1, 2026
uMI Panvivo Family - Empowering Tomorrow for All
Sponsored
uMI Panvivo Family - Empowering Tomorrow for All
February 10, 2026
Snmmi Thumb
SNMMI: Machine-learning model predicts RPT dose
May 30, 2026
Related Stories
2012 05 23 11 02 22 474 2012 05 23 France Pet Ct Thumb
Body Imaging
French survey highlights wide dose discrepancies in PET/CT
2012 03 16 11 04 37 25 German Flag Button 70
Clinical News
German national congress offers new features and fresh approach
2012 05 02 08 54 45 886 2012 05 02 Pet Thumb2
Clinical News
PET can prove effective for measuring tumor vascularity
uMI Panvivo Family - Empowering Tomorrow for All
Sponsor Content
uMI Panvivo Family - Empowering Tomorrow for All
More in Molecular Imaging
Early FAPI-PET scans match 60-minute scans for lung cancer staging
By Will Morton
By convention, most molecular imaging tracers such as F-18 FDG are injected one hour prior to PET scans to allow time for uptake of the tracer by tumors.
June 10, 2026
PET/CT images performed at 10- and 60-minutes following injection of Ga-68 FAPI-46 (mean 181 MBq; range 143–225 MBq).
Curium to invest €32M in French radiopharmaceutical facility
By AuntMinnieEurope.com staff writers
The investment will go toward development of a new production line for lutetium-177 PSMA-I&T, a targeted radioligand therapy.
June 1, 2026
France Flag Button 400
SNMMI: SPECT/CT tracer shows promise in interstitial lung disease
By Will Morton
Differentiating between fibrotic scarring and inflammation stages of disease is critical so that physicians can determine what treatment is best for the patient.
May 31, 2026
Sample images from each participant group: A: CT only; B: fused Tc-99m maraciclatide SPECT/CT.
SNMMI: Machine-learning model predicts RPT dose
By Will Morton
Dosimetry plays a central role in optimizing lutetium-177 (Lu-177) PSMA therapy, yet calculating it currently depends on post-therapy imaging.
May 30, 2026
Snmmi Thumb
Eye movement abnormalities flag brain health risk in ex-racing drivers
By Kate Madden Yee
A case series of 12 male retired professional motorsport drivers showed a high prevalence of mild neurological abnormalities.
May 29, 2026
Racecare Thumb
Health Canada clears latest Hermia molecular imaging update
By AuntMinnie.com staff writers
The clearance allows for Hermia's clinical use across Canadian nuclear medicine and theranostics practices.
May 28, 2026
Am 2014 02 11 15 10 50 886 Canadian Flag 200 (1)
FDG-PET/CT predicts outcomes in patients with HCC
By Will Morton
Elevated FDG uptake was consistently associated with poorer overall survival.
May 22, 2026
A graphical abstract of the study.
AuntMinnieEurope Molecular Imaging Insider
By Claudia Tschabuschnig
This edition covers the latest in PET/CT quality assurance, theranostics pipeline updates, AI in nuclear medicine, and policy developments shaping the field across Europe.
May 6, 2026
How AI can help with PET/CT guideline deviations
By Claudia Tschabuschnig
Researchers have found a gap between what international PET/CT guidelines recommend and what actually happens in clinical practice.
May 6, 2026
Pet Ct Scan Fusion Image
The EANM joins EMUC26 and pushes its policy agenda in Brussels
By Claudia Tschabuschnig
Decisions shaping who gets access to theranostics in Europe have long been made mainly in the clinic. With EANM opening a Brussels office and joining EMUC26 as co-organizer, a full policy agenda arrives at the EU table.
May 5, 2026
Ean Mcongress
Serac highlights study on 99mTc-maraciclatide for endometriosis care
By AuntMinnie.com staff writers
Serac Healthcare is highlighting success from a study that evaluated the company's gamma-emitting radiotracer, 99mTc-maraciclatide.
April 30, 2026
Endometriosis 3 D Illustration 400
Lu-177 PSMA-SPECT/CT predicts survival in mCRPC
By Will Morton
Lu-177 PSMA-617 SPECT/CT total tumor volume complete response at six weeks associated with overall survival.
April 29, 2026
Quantification of total tumor volume (TTV) at lutetium-177 prostate-specific membrane antigen (PSMA)–617 SPECT/CT shows heterogeneous TTV responses between dose 1 (Cycle #1) and dose 2 (Cycle #2) in participants with metastatic castration-resistant prostate cancer. Posttherapy coronal attenuation-corrected noncontrast SPECT/CT maximum intensity projection images demonstrate (A) near-complete response in a 76-year-old man, (B) complete response in an 83-year-old man, (C) partial TTV reduction (not complete response) in a 69-year-old man, and (D) TTV increase (i.e. progressive disease) in a 74-year-old man. Blue-shaded regions represent semiautomatically segmented PSMA-avid tumor volume, with associated TTV values given at the bottom of each panel. The gradient bar shows standardized uptake value (SUV) from 0 to 5.
Page 1 of 127
Next Page